Clinical-Trial Investigators’ Assessment of Serious Adverse Events Before and After Unblinding of Suspected Unexpected Serious Adverse Reactions (SUSARs)
Keyword(s):
2019 ◽
Vol 21
(Supplement_6)
◽
pp. vi16-vi16
◽
Keyword(s):
2014 ◽
Vol 21
(11)
◽
pp. 1560-1564
◽
Keyword(s):
2018 ◽
Vol 104
(2)
◽
pp. F171-F175
◽
Keyword(s):
2016 ◽
Vol 43
(2)
◽
pp. 284-290
◽
2020 ◽
Vol 38
(6_suppl)
◽
pp. 136-136
2020 ◽
Vol 14
(Supplement_1)
◽
pp. S511-S513
2020 ◽
Vol 2020
◽
pp. 1-9
Keyword(s):